Labcorp’s (NYSE:LH) Q3 2026 sales beat estimates
Labcorp reported Q3 2026 revenue of $3.81B, exceeding estimates by 1.2% and growing 6.9% YoY. Adjusted EPS was $4.78, a 2.9% beat. The company raised full-year revenue and EPS guidance. Operating margin remained steady at 10.6%, while free cash flow margin improved to 10.8%. Organic revenue grew 5.5% YoY.
How this was made
The 30-second read
Why it matters
A revenue and adjusted EPS beat, combined with slightly higher full-year guidance, can drive re-rating of near-term earnings expectations and improve confidence in cash generation.
Market read
Traders can update positioning around Labcorp’s earnings trajectory and guidance, especially given the reported improvement in free cash flow margin.
What to watch
Free cash flow margin improved sharply year over year, but the article does not attribute drivers (working capital vs operational leverage), which could affect how sustainable the cash flow strength is.
Background
The piece summarizes Labcorp’s Q3 2026 results versus S&P analysts’ consensus and notes small full-year guidance increases.
Ticker impact
Labcorp reported Q3 2026 revenue of $3.81B and adjusted EPS of $4.78, beating consensus and slightly lifting full-year guidance.
Likely upward bias as the market reprices earnings power and the raised guidance midpoint.
The article provides specific Q3 beat figures and states management slightly lifted full-year revenue and adjusted EPS guidance at the midpoint.
Market effects
Supports the broader healthcare services/lab testing demand narrative by signaling resilient organic growth and improving cash flow conversion.
Primarily US-listed sentiment for managed care and diagnostics-adjacent equities.
Limited direct global spillover beyond investor sentiment toward US healthcare services earnings quality.
Counterpoint
The guidance lift is described as slight, so upside may be capped if investors expected a larger raise or if margins/cash flow improvements prove temporary.
Key entities
- companyLabcorp
Reported Q3 2026 revenue and adjusted EPS beats, and slightly lifted full-year revenue and adjusted EPS guidance at the midpoint.
